Filing Details

Accession Number:
0000711377-21-000011
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-01 18:40:46
Reporting Period:
2021-03-30
Accepted Time:
2021-04-01 18:40:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1651434 Edward John Adent 822 7Th Street, Suite 740
Greeley CO 80631
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-30 9,536 $62.70 29,616 No 4 M Direct
Common Stock Disposition 2021-03-30 9,536 $87.09 20,080 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2021-03-30 9,536 $0.00 9,536 $62.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
283,340 2023-12-01 No 4 M Direct
Footnotes
  1. Options were granted 11/1/2018, have five year lives and vest in equal annual 20% installments on each of the first five anniversary dates of the grant